A FIT test is not as accurate as a colonoscopy in a single sitting, but when used consistently over time, it can be comparably effective at catching colorectal cancer. A colonoscopy detects more than 99% of colorectal cancers in one exam. A FIT test catches about 80%. That gap sounds significant, but it narrows considerably when you factor in real-world behavior: how often people actually complete each test and how the annual repetition of FIT compensates for its lower one-time sensitivity.
The two tests work in fundamentally different ways, serve different roles, and come with different tradeoffs. Understanding those differences will help you figure out which screening approach fits your situation.
How Each Test Actually Works
A colonoscopy is a direct visual exam. A doctor guides a flexible camera through your entire colon, looking for polyps, abnormal tissue, and cancer. If they spot a precancerous polyp, they can remove it on the spot, which means a colonoscopy is both a screening tool and a preventive procedure. It requires a full bowel preparation the day before (drinking a large volume of laxative solution), sedation during the procedure, and someone to drive you home afterward. For average-risk adults, it’s recommended every 10 years.
A FIT test (fecal immunochemical test) is a stool sample you collect at home. It uses antibodies that detect human hemoglobin, the oxygen-carrying protein in blood. Because hemoglobin breaks down as it travels through the upper digestive tract, FIT is specifically tuned to pick up bleeding from the colon and rectum, where colorectal cancers and large polyps tend to bleed. There’s no prep, no sedation, and no time off work. It’s recommended once a year.
Detection Rates Compared
On a single-use basis, colonoscopy wins clearly. It identifies more than 99% of colorectal cancers present at the time of the exam. FIT detects about 80%, meaning it would catch 8 out of 10 cancers. A newer stool-based option, the stool DNA-FIT combination test, raises that figure to about 92%.
Where FIT falls shorter is with precancerous polyps. Polyps don’t always bleed, so a test that relies on detecting blood will miss many of them. Colonoscopy can spot and remove polyps before they ever become cancerous, which is its unique advantage. FIT is primarily designed to catch cancer or large, advanced polyps that have started to bleed.
Colonoscopy isn’t perfect either, though. Back-to-back colonoscopy studies show that about 17% of adenomas (precancerous polyps) are missed during a standard exam. The miss rate climbs to nearly 23% for very small polyps under 5 mm. For larger, more dangerous advanced adenomas, the miss rate drops to around 5%. Factors like bowel prep quality, the speed of the exam, and the physician’s experience all influence how much gets seen.
Why Annual FIT Can Close the Gap
The key insight most people miss is that FIT isn’t meant to be a one-and-done test. You take it every year. A polyp or cancer that doesn’t bleed enough to trigger a positive result this year may bleed next year or the year after. Over a decade, ten annual FIT tests create ten chances to catch something, compared to a colonoscopy’s single snapshot.
Modeling studies have found that when people actually stick with annual FIT at adherence rates of 65% to 70% or higher, the number of colorectal cancer cases and deaths prevented equals or exceeds those prevented by colonoscopy at its real-world adherence rate of about 38%. That’s the critical point: the best screening test is the one you actually complete. In studies comparing uptake, about 43% of people offered FIT followed through, compared to 38% offered colonoscopy. That difference, compounded over years of repeat testing, matters.
Cost and Accessibility
A FIT kit costs roughly $40. A colonoscopy runs around $1,279 on average when you include the procedure, bowel preparation, and time costs. Under the Affordable Care Act, both are covered as preventive screening without a copay for most insured adults, but out-of-pocket costs can still arise. If polyps are found and removed during a colonoscopy, the procedure may be reclassified from screening to diagnostic, which can trigger cost-sharing depending on your insurance plan.
FIT also removes several practical barriers. There’s no need for sedation, no missed workday, and no arranging a ride home. For people without easy access to a gastroenterologist, or those who can’t take time off, this accessibility can be the difference between getting screened and not getting screened at all.
Risks of Each Approach
FIT carries essentially no physical risk. It’s a stool sample. The main downside is the possibility of a false positive, which leads to an unnecessary colonoscopy, or a false negative, which provides false reassurance for a year.
Colonoscopy is very safe but not risk-free. Colonic perforation, where the instrument creates a small tear in the colon wall, occurs in roughly 0.6 to 0.7 per 1,000 procedures. Other complications include post-polypectomy bleeding and adverse reactions to sedation. For most healthy adults these risks are small, but they’re not zero, and they’re worth weighing if you’re deciding between screening options.
What Happens After a Positive FIT
A positive FIT result doesn’t mean you have cancer. It means blood was detected in your stool, which could come from hemorrhoids, inflammatory conditions, or other benign causes. But it does require a follow-up colonoscopy to determine the source. This is a non-negotiable part of FIT-based screening. If you choose FIT as your screening method, you’re committing to getting a colonoscopy if the result comes back positive. Delaying that follow-up colonoscopy is associated with worse outcomes if cancer is present.
Roughly 5% to 10% of FIT tests come back positive, so most people using FIT will never need the follow-up procedure in a given year. But over a decade of annual testing, the cumulative chance of at least one positive result is higher.
Which Test Is Right for You
For average-risk adults between 45 and 75, both FIT and colonoscopy are recommended screening strategies by the U.S. Preventive Services Task Force. Neither is considered inherently superior as a screening program, because real-world effectiveness depends on adherence, not just per-test accuracy.
Colonoscopy is the stronger choice if you want a single thorough exam with the added benefit of polyp removal, and you’re willing to do the prep and take the day. It’s also the necessary choice for people at higher risk due to family history, inflammatory bowel disease, or a previous positive stool test.
FIT makes the most sense if you prefer a low-burden test you can do at home, as long as you’re genuinely committed to doing it every year and following up promptly if it’s positive. Skipping years or ignoring a positive result eliminates the advantage that annual repetition provides. A FIT test sitting unused in a drawer prevents exactly zero cancers.
The bottom line: a colonoscopy is more accurate in any single exam. But a FIT test done reliably every year is a legitimate, evidence-backed alternative that catches the vast majority of colorectal cancers and saves just as many lives when people actually follow through.